1. 122TiPGeparDouze/NSABP B-59: A randomized double-blind phase III clinical trial of neoadjuvant chemotherapy with atezolizumab or placebo in patients with triple negative breast cancer (TNBC) followed by adjuvant atezolizumab or placebo. (13th May 2019) Authors: Loibl, S; Jackisch, C; Rastogi, P; Seiler, S; Lucas, P C; Denkert, C; Costantino, J; Nekljudova, V; Wolmark, N; Geyer, C Journal: Annals of oncology Issue: Volume 30(2019)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 273PD_PRFinal analysis of the Male-GBG54 study: A prospective, randomised multi-centre phase II study evaluating endocrine treatment with either tamoxifen +/- gonadotropin releasing hormone analogue (GnRHa) or an aromatase inhibitor + GnRHa in male breast cancer patients. (23rd October 2018) Authors: Reinisch, M; Seiler, S; Hauzenberger, T; Schmatloch, S; Strittmatter, H-J; Zahm, D-M; Thode, C; Jackisch, C; Strik, D; Moebus, V; Reimer, T; Sinn, B; Stickeler, E; Marme, F; Janni, W; Kamischke, A; Rudlowski, C; Nekljudova, V; von Minckwitz, G; Loibl, S Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 369TiPPATINA: A randomized, open label, phase III trial to evaluate the efficacy and safety of palbociclib + Anti-HER2 therapy + endocrine therapy (ET) vs. anti-HER2 therapy + ET after induction treatment for hormone receptor positive (HR+)/HER2-positive metastatic breast cancer (MBC). (23rd October 2018) Authors: Loibl, S; Metzger, O; Mandrekar, S J; Mundhenke, C; Seiler, S; Valagussa, P; DeMichele, A; Lim, E; Tripathy, D; Winer, E P; Huang, C; Carey, L; Francis, P; Miller, K D; Goetz, M P; Prat, A; Loi, S; Krop, I; Gianni, L; Ciruelos, E M Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Impaired weight gain predicts risk of late death after surgery for congenital heart defects. Issue 6 (29th January 2008) Authors: Eskedal, L T; Hagemo, P S; Seem, E; Eskild, A; Cvancarova, M; Seiler, S; Thaulow, E Journal: Archives of disease in childhood Issue: Volume 93:Issue 6(2008) Page Start: 495 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗